Goodwin Procter LLP advised Cerevance on the closing of its $45 million Series B financing. Cerevance, a private drug discovery and development company focused on brain…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now